The NCRI Lung Group brings together clinicians, scientists and patients, carers and others affected by cancer (also known as ‘consumers’), amongst many others, to coordinate the development of a strategic portfolio of research within the field of lung cancer. The group works closely with clinical research networks, funders and researchers to develop research to improve outcomes for lung cancer patients.
The NCRI Lung Group consists of an executive group, chaired by Dr Matthew Hatton, which provides oversight of the research landscape and proactively identifies opportunities for the group. The NCRI Lung Group also has several subgroups that develop research in areas of strategic need.
Members are competitively recruited to the executive Group and subgroups twice a year and are advertised on the jobs and opportunities page. If there are not currently any vacancies, you are encouraged to register your interest via email.
Group Chair: Dr Matthew Hatton
